# Lunai Bioworks Inc. (RENB)

Source: https://www.quantisnow.com/company/RENB
Generated: 2026-11-16T01:39:58.661Z

- Ticker: RENB
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations

## Latest RENB news and filings

- 2025-11-14 21:08 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Lunai Bioworks Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-lunai-bioworks-inc-6280462)
- 2025-11-06 21:22 UTC [SEC Form 8-K] [Lunai Bioworks Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/lunai-bioworks-inc-filed-sec-form-8-k-notice-of-delisting-6265976)
- 2025-11-03 21:31 UTC [SEC Form 8-K] [Lunai Bioworks Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lunai-bioworks-inc-filed-sec-form-8-k-submission-of-matters-6256912)
- 2025-10-30 13:15 UTC [SEC Form 8-K] [Lunai Bioworks Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/lunai-bioworks-inc-filed-sec-form-8-k-notice-of-delisting-6251752)
- 2025-10-16 19:21 UTC [SEC Form 8-K] [Lunai Bioworks Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lunai-bioworks-inc-filed-sec-form-8-k-notice-of-delisting-6235499)
- 2025-10-15 16:06 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Lunai Bioworks Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-lunai-bioworks-inc-6233774)
- 2025-09-30 13:15 UTC [Market Insight] [Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense](https://www.quantisnow.com/insight/lunai-bioworks-unveils-new-corporate-identity-streamlined-capital-structure-and-6215637)
- 2025-09-29 19:56 UTC [SEC Form 10-K] [SEC Form 10-K filed by Lunai Bioworks Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-lunai-bioworks-inc-6214332)
- 2025-09-25 12:30 UTC [Market Insight] [Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships](https://www.quantisnow.com/insight/lunai-bioworks-advances-biomarker-discovery-preclinical-program-in-parkinsons-disease-6211469)
- 2025-09-24 20:50 UTC [Market Insight] [Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split](https://www.quantisnow.com/insight/lunai-bioworks-inc-to-effect-101-reverse-stock-split-6210816)
- 2025-09-24 20:30 UTC [SEC Form 8-K] [Lunai Bioworks Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lunai-bioworks-inc-filed-sec-form-8-k-material-modification-to-6210757)
- 2025-09-11 11:00 UTC [Market Insight] [Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics](https://www.quantisnow.com/insight/lunai-bioworks-subsidiary-biosymetrics-and-brigham-and-womens-hospital-awarded-6197265)
- 2025-09-09 12:47 UTC [Market Insight] [Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery](https://www.quantisnow.com/insight/lunai-bioworks-inc-unveils-transformer-platform-to-secure-generative-ai-6194494)
- 2025-09-08 12:50 UTC [Market Insight] [Lunai Bioworks Strengthens European Strategy Through Restructuring](https://www.quantisnow.com/insight/lunai-bioworks-strengthens-european-strategy-through-restructuring-6192743)
- 2025-09-05 21:12 UTC [SEC Form 8-K] [Renovaro Inc. filed SEC Form 8-K: Other Events, Material Impairments](https://www.quantisnow.com/insight/renovaro-inc-filed-sec-form-8-k-other-events-material-impairments-6192038)
- 2025-09-04 14:05 UTC [Market Insight] [Lunai Bioworks Inc. Retains American Defense International](https://www.quantisnow.com/insight/lunai-bioworks-inc-retains-american-defense-international-6189649)
- 2025-08-27 13:45 UTC [Market Insight] [Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics](https://www.quantisnow.com/insight/renovaro-inc-announces-corporate-name-change-to-lunai-bioworks-inc-6180401)
- 2025-08-26 20:45 UTC [SEC Form 8-K] [Renovaro Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/renovaro-inc-filed-sec-form-8-k-amendments-to-articles-of-6179448)
- 2025-08-08 14:45 UTC [Market Insight] [Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks](https://www.quantisnow.com/insight/renovaro-inc-nasdaq-renb-mentioned-in-realcleardefense-article-on-ai-6155801)
- 2025-08-06 15:51 UTC [SEC Form 8-K] [Renovaro Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/renovaro-inc-filed-sec-form-8-k-notice-of-delisting-or-6149709)
- 2025-07-30 17:08 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Renovaro Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-renovaro-inc-6138194)
- 2025-07-29 19:01 UTC [AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks](https://www.quantisnow.com/insight/ai-just-got-a-green-light-from-the-white-house--heres-6136269)
- 2025-07-28 14:38 UTC [Market Insight] [Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector](https://www.quantisnow.com/insight/renovaro-secures-key-ai-patents-strengthening-market-position-in-20b-6134066)
- 2025-07-25 21:13 UTC [SEC Form 8-K] [Renovaro Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/renovaro-inc-filed-sec-form-8-k-leadership-update-6133361)
- 2025-07-18 20:16 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Renovaro Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-renovaro-inc-6125531)
- 2025-07-17 13:15 UTC [Market Insight] [Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy](https://www.quantisnow.com/insight/peer-reviewed-study-validates-renovaros-genetically-engineered-dendritic-cell-therapy-with-6123339)
- 2025-07-14 13:18 UTC [SEC Form 8-K] [Renovaro Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/renovaro-inc-filed-sec-form-8-k-notice-of-delisting-or-6118907)
- 2025-07-09 12:00 UTC [Market Insight] [Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives](https://www.quantisnow.com/insight/renovaro-strengthens-balance-sheet-through-debt-conversion-and-advances-ai-driven-6114922)
- 2025-07-08 23:43 UTC [SEC Form 8-K] [Renovaro Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/renovaro-inc-filed-sec-form-8-k-entry-into-a-material-6114759)
- 2025-06-30 13:21 UTC [Market Insight] [Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs](https://www.quantisnow.com/insight/renovaro-launches-ai-based-neurotoxin-countermeasure-initiative-addressing-emerging-national-security-6103175)
- 2025-06-10 15:13 UTC [Smart Healthcare Is Taking Over. Here's Where the Money's Headed](https://www.quantisnow.com/insight/smart-healthcare-is-taking-over-heres-where-the-moneys-headed-6080068)
- 2025-06-05 20:02 UTC [SEC Form 8-K] [Renovaro Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/renovaro-inc-filed-sec-form-8-k-leadership-update-6074269)
- 2025-06-03 13:15 UTC [Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform](https://www.quantisnow.com/insight/renovaro-secures-key-us-patent-to-strengthen-ai-driven-drug-discovery-6069175)
- 2025-05-22 19:12 UTC [Public Offering] [UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology](https://www.quantisnow.com/insight/update---renovaro-inc-announces-expedited-trial-for-2025-lawsuit-6054096)
- 2025-05-22 15:05 UTC [Public Offering] [Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology](https://www.quantisnow.com/insight/renovaro-inc-announces-expedited-trail-for-2025-lawsuit-to-enforce-6053908)
- 2025-05-15 20:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Renovaro Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-renovaro-inc-6043015)
- 2025-05-14 13:15 UTC [Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform](https://www.quantisnow.com/insight/renovaro-launches-augusta-an-ai-powered-precision-neurology-platform-6037951)
- 2025-05-13 13:15 UTC [Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics](https://www.quantisnow.com/insight/renovaro-and-amsterdam-university-medical-center-announce-exclusive-collaboration-to-6035059)
- 2025-04-22 13:20 UTC [Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs](https://www.quantisnow.com/insight/renovaro-secures-high-powered-computing-from-nebul-through-a-partnership-to-5995960)
- 2025-04-18 21:00 UTC [SEC Form 8-K] [Renovaro Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/renovaro-inc-filed-sec-form-8-k-notice-of-delisting-or-5993799)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/RENB
- Earnings history: https://www.quantisnow.com/earnings/RENB
- Dividend history: https://www.quantisnow.com/dividends/RENB
- Insider transactions: https://www.quantisnow.com/insiders/RENB
- Options chain: https://www.quantisnow.com/options/RENB
- SEC 8-K filings only: https://www.quantisnow.com/company/RENB/8-k
- RSS and alerts for RENB: https://www.quantisnow.com/docs/rss-feeds.md
